Hyderabad-based drugmaker Suven to shop for majority stake in NJ Bio for $64 million
MUMBAI Mumbai: Hyderabad-based contract drug producer (CDMO) Suven Prescription drugs has agreed to shop for 56 in step with cent stake in most cancers drug maker NJ Bio for $64.4 million. The combo of number one and secondary proportion purchases values the objective company at $100 million. Of the overall fee, Suven pays $49.4 million … Read more